Skip to content
FREE AUSTRALIA-WIDE DELIVERY ON ORDERS +$175 AUD
FREE AUSTRALIA-WIDE DELIVERY ON ORDERS +$175 AUD

Cell-Logic EnduraCELL Plus 60Caps

$49.95

Notify me when back in stock

The unique phytonutrients contained in broccoli sprouts may activate the body’s natural cellular detoxification processes and antioxidant defences. Scientific research indicates that selenium (an essential trace element in human nutrition) supports antioxidant activity in the body. When taken as directed, this product assists in the maintenance and improvement of general well being.

The EnduraCell® Plus formulation is based on the same grade and quantity of EnduraCell® but with the addition of 25 mcg selenium per capsule. Many of the enzymes which increase cellular defences, depend upon seleno-enzymes.

EnduraCell® Plus may:

  • Stimulate cellular antioxidant defences within the body
  • Activate key enzymes in liver detoxification
  • Support selenium deficient diets
  • Aid thyroid metabolism and protection
  • Support gut homeostasis and immune function

        Recommended Daily Dosage:

        Adults: take 1- 2 capsules twice daily, or as directed by your Health Care Practitioner. Do not exceed 6 capsules daily.

        Ingredients:

        Each size ’00’ capsule contains:

        EnduraCell® 100% Whole Broccoli Sprout Powder (Brassica oleracea var. italica sprout powder): 700mg

        Selenomethionine: 62.5mcg (Eqv. 25 mcg selenium)

        Cell-Logic EnduraCell® is hydroganically grown in a carefully controlled environment to maximise bioactivity. Our hydroganic growing process does not use any herbicides, pesticides or other harmful chemicals. EnduraCell® Plus is GMO free and does not contain goitrogens or significant levels of Vitamin K.

        Warnings:

        This product contains selenium which is toxic in high doses. For adults, a daily dose of 150 micrograms of selenium from dietary supplements should not be exceeded.

        Store below 30°C away from light and moisture.

        Do not exceed 6 capsules daily.

        Very occasionally, gastro-intestinal adverse effects have been reported, and include nausea, gastro-abdominal discomfort and diarrhoea. Limited data available seem to indicate that such effects are limited to certain pre-existing gastro-intestinal conditions, in particular, those with dysbiosis. However, it has been observed that for those affected, the dose can be managed in a manner whereby the symptoms disappear and may not recur even after the consumption of larger doses.